Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective

The pandemic of Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 has induced global eagerness to develop vaccines and therapeutics for treating COVID-19, including neutralizing antibodies. To develop effective therapeutic antibodies against SARS-CoV-2, it is critical to understand the intera...

Descripción completa

Detalles Bibliográficos
Autores principales: Khatri, Indu, Staal, Frank J. T., van Dongen, Jacques J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527437/
https://www.ncbi.nlm.nih.gov/pubmed/33042151
http://dx.doi.org/10.3389/fimmu.2020.570018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527437/
https://www.ncbi.nlm.nih.gov/pubmed/33042151
http://dx.doi.org/10.3389/fimmu.2020.570018

Ejemplares similares